{"ticker": {"uuid": "6247db74-2c96-439e-85d8-f72660e7d071", "symbol": "NSPR", "name": "InspireMD Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "InspireMD director Raymond W. Cohen to resign from board effective July 1, 2026", "summary": "Raymond W. Cohen is resigning from his position as a Class III Director at InspireMD, effective July 1, 2026, due to personal considerations. He also served on the Audit Committee and Compensation Committee. The company's Nominating and Corporate Governance Committee will be resp", "url": "https://www.tradingview.com/news/tradingview:812d859cb06a6:0-inspiremd-director-raymond-w-cohen-to-resign-from-board-effective-july-1-2026/", "source_name": "TradingView", "published_at": "2026-07-03T07:29:37", "published_display": "03 Jul 2026 07:29", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Board member Raymond Cohen to leave InspireMD (NSPR) effective July 1, 2026", "summary": "InspireMD, Inc. reported that board member Raymond W. Cohen, a Class III director and member of the Audit and Compensation Committees, will resign effective July 1, 2026. His resignation is for personal considerations and is not due to any disagreement with the company. The Nomin", "url": "https://www.stocktitan.net/sec-filings/NSPR/8-k-inspire-md-inc-reports-material-event-a40e8150aab0.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:39:37", "published_display": "02 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $4", "summary": "Lake Street has reiterated its Buy rating on InspireMD (NSPR.US) but has adjusted its price target for the stock down to $4. This indicates a continued positive outlook on the company despite a revised valuation.", "url": "https://www.moomoo.com/news/post/69344277/lake-street-maintains-inspiremd-nsprus-with-buy-rating-cuts-target", "source_name": "Moomoo", "published_at": "2026-06-30T16:40:33", "published_display": "30 Jun 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD, Inc.(NasdaqCM: NSPR) dropped from Russell 3000E Growth Benchmark", "summary": "InspireMD, Inc. (NasdaqCM: NSPR) has been removed from the Russell 3000E Growth Benchmark. This news comes after several recent announcements from InspireMD regarding recalling actions on its CGuard Prime Carotid Stent System and enrolling the first patient in a new pivotal study", "url": "https://www.marketscreener.com/news/inspiremd-inc-nasdaqcm-nspr-dropped-from-russell-3000e-growth-benchmark-ce7f5fdeda8ef125", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T05:13:20", "published_display": "29 Jun 2026 05:13", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD, Inc.(NasdaqCM:NSPR) dropped from Russell Microcap Growth Benchmark Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPT3RKRzBlWFk2S2p1MnktbENWRFVoNXdpLS1jeFVKNllhT0Fycmp2OVJGb1ZIanVTS09mZmpwMHFhS19QVWVWeG9DQm9keFpPQ3NoRXUyM2I5emk1OEhfcnljaVN0V0pVNVJOQlJZT0lTMlhnU1o0TGMzYzRlVzdIcEVJYTAxUVhUZEhwaUpKd3FfWElTVmFWWFJHcmh5empRX0kwZ2JPenBVUVhmWG9kSnNRZTJtaTRrdmhVNC1yRVRUUy1DMmlXdjN2eVJkZw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NSPR Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a stock forecast for InspireMD Inc. (NSPR) for 2027, including analyst price targets, historical performance data, and key financial metrics. It details the current stock price, volatility, market capitalization, and upcoming earnings report date, also highl", "url": "https://www.tradingview.com/symbols/NASDAQ-NSPR/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-28T07:40:38", "published_display": "28 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of InspireMD Inc. \u2013 NASDAQ:NSPR", "summary": "This article provides financial data for InspireMD Inc. (NASDAQ:NSPR), specifically focusing on its price-to-book forward ratio. It appears to be an entry from a financial data platform, displaying market information, but the actual numerical value for the price-to-book forward r", "url": "https://www.tradingview.com/symbols/NASDAQ-NSPR/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T17:10:09", "published_display": "27 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of InspireMD Inc. \u2013 NASDAQ:NSPR", "summary": "This article provides the \"Price to sales forward\" value for InspireMD Inc. (NASDAQ: NSPR). The financial data is delivered by TradingView, sourcing information from ICE Data Services and FactSet Research Systems Inc.", "url": "https://www.tradingview.com/symbols/NASDAQ-NSPR/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:40:37", "published_display": "27 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of InspireMD Inc. \u2013 NASDAQ:NSPR", "summary": "This article provides financial data for InspireMD Inc. (NASDAQ: NSPR), specifically focusing on its enterprise value to revenue forward. It appears to be a stub or a data point from a financial platform like TradingView, with no further analytical content but highlights the comp", "url": "https://www.tradingview.com/symbols/NASDAQ-NSPR/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T01:40:14", "published_display": "26 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of InspireMD Inc. \u2013 NASDAQ:NSPR", "summary": "This page from TradingView provides financial data for InspireMD Inc. (NASDAQ:NSPR), specifically focusing on its enterprise value to EBITDA forward metric. The content highlights the company's financial overview within the health technology and medical specialties sector.", "url": "https://www.tradingview.com/symbols/NASDAQ-NSPR/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T20:11:03", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of InspireMD Inc (NSPR), listing its major shareholders, their proportion of holdings, and recent changes in their positions. It also provides institutional shareholding data over several quarters, showing the number of institutions,", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T11:10:35", "published_display": "18 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Institutional Confidence", "summary": "InspireMD Inc (NSPR) has an institutional shareholding score of 3.00, placing it 132nd out of 203 in the Healthcare Equipment & Supplies industry. Institutional holdings represent 49.38% of shares outstanding, a 9.65% decrease quarter-over-quarter. James Simons is the largest ins", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T11:09:11", "published_display": "18 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides details on InspireMD Inc (NSPR)'s dividend and stock split history. It notes that the company has not distributed dividends in the past five years and lists several 15-to-1 merger-type stock splits that occurred on April 15, 2021. The article also presents c", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T21:09:43", "published_display": "17 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of InspireMD Inc (NSPR), detailing its current price momentum score of 5.92 and noting it trades between resistance at $0.96 and support at $0.58. It breaks down various technical indicators, with a majority signaling \"Sell,\" and highlig", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/technical", "source_name": "TradingKey", "published_at": "2026-06-17T11:09:06", "published_display": "17 Jun 2026 11:09", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Financial Health: Profitability & Balance Sheet Analysis", "summary": "InspireMD Inc's current financial score is 6.38, ranking 157 out of 203 in its industry, indicating robust financial status but low operating efficiency. The company reported a 122.24% year-over-year increase in quarterly revenue to $3.40M and a 22.60% increase in net profit. Key", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T11:09:05", "published_display": "17 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "InspireMD Inc (NSPR) has an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $4.50, with forecasts ranging from $4.00 to $5.00, suggesting a significant upside. The market expects NSPR t", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T11:09:05", "published_display": "17 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR", "summary": "InspireMD announced positive 30-day results from its CGUARDIANS II clinical trial for the CGuard Prime 80 cm carotid stent implant used in TCAR procedures, meeting key safety and efficacy endpoints with a 100% acute device success rate and no adverse events. This data supports po", "url": "https://finance.yahoo.com/healthcare/articles/inspiremd-posts-positive-cguardians-ii-164100594.html", "source_name": "Market source", "published_at": "2026-06-16T11:41:17", "published_display": "16 Jun 2026 11:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "InspireMD announces inducement grants", "summary": "InspireMD, Inc. has announced that its Compensation Committee approved inducement grants of 91,161 shares of restricted stock to six new non-executive employees. These grants, made outside of the company's 2021 Equity Incentive Plan under the 2024 Inducement Plan, are intended to", "url": "https://medicalbuyer.co.in/inspiremd-announces-inducement-grants-3/", "source_name": "Medical Buyer", "published_at": "2026-06-15T10:09:34", "published_display": "15 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "InspireMD, Inc. (Nasdaq: NSPR) announced that its Compensation Committee approved inducement grants of 91,161 shares of restricted stock to six new non-executive employees. These grants were made outside of the company's 2021 Equity Incentive Plan but under the 2024 Inducement Pl", "url": "https://www.manilatimes.net/2026/06/13/tmt-newswire/globenewswire/inspiremd-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/2364711", "source_name": "The Manila Times", "published_at": "2026-06-12T20:09:19", "published_display": "12 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Six new InspireMD employees receive 91,161-share stock grants", "summary": "InspireMD (Nasdaq: NSPR) has announced inducement grants of 91,161 restricted shares to six new non-executive employees under its 2024 Inducement Plan. These equity awards, granted outside the 2021 Equity Incentive Plan per Nasdaq Listing Rule 5635(c)(4), will vest over three yea", "url": "https://www.stocktitan.net/news/NSPR/inspire-md-announces-inducement-grants-under-nasdaq-listing-rule-73rxuoq82m9y.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:09:19", "published_display": "12 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD, Inc. (NSPR) reports Q1 loss, tops revenue estimates", "summary": "InspireMD, Inc. (NSPR) announced its first-quarter financial results, reporting a loss per share that was wider than analyst expectations but surpassing revenue estimates. The company posted a loss of 19 cents per share against an anticipated loss of 18 cents, while revenue reach", "url": "https://www.msn.com/en-us/money/other/inspiremd-inc-nspr-reports-q1-loss-tops-revenue-estimates/ar-AA22nYF5?ocid=BingNewsVerp", "source_name": "MSN", "published_at": "2026-06-12T00:39:46", "published_display": "12 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/inspiremd-announces-30-day-results-120000676.html", "source_name": "GlobeNewswire", "published_at": "2026-06-11T12:00:00+00:00", "published_display": "11 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stroke-prevention stent hits 100% success in 50 high-risk patients", "summary": "InspireMD (NSPR) announced 30-day results from its CGUARDIANS II clinical trial for the CGuard Prime 80 cm stent used in TCAR procedures, showing 100% acute device success and no major adverse events in 50 high-risk patients. The company has a PMA supplement under FDA review with", "url": "https://www.stocktitan.net/news/NSPR/inspire-md-announces-30-day-results-from-the-cguardians-ii-clinical-84bv5ee39qxg.html", "source_name": "Stock Titan", "published_at": "2026-06-11T12:39:26", "published_display": "11 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) reports 100% device success in TCAR trial", "summary": "InspireMD (NSPR) announced strong 30-day results from its CGUARDIANS II clinical trial for the CGuard Prime 80 cm implant used in TCAR procedures, showing 100% device success and no major adverse events in 50 patients. The company has a Premarket Approval supplement under FDA rev", "url": "https://www.stocktitan.net/sec-filings/NSPR/8-k-inspire-md-inc-reports-material-event-1b822d3a9585.html", "source_name": "Stock Titan", "published_at": "2026-06-11T11:39:26", "published_display": "11 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures", "summary": "InspireMD has announced the enrollment of the first patient in its CGUARDIANS III pivotal study, evaluating the SwitchGuard neuro protection system for use in TCAR procedures with the CGuard Prime 80 cm stent. This study aims to enhance patient safety and stroke prevention, build", "url": "https://www.globenewswire.com/news-release/2026/06/08/3308025/0/en/inspiremd-announces-first-patient-enrolled-in-the-cguardians-iii-pivotal-study-of-the-switchguard-neuro-protection-system-for-use-in-tcar-procedures.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T06:40:38", "published_display": "09 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NSPR - InspireMD Inc Stock Price and Quote", "summary": "This page provides a detailed overview of InspireMD Inc (NSPR) stock, including its current trading price, financial metrics, performance indicators, and recent news. It lists key financial data such as market cap, income, sales, and various ratios, alongside insider transaction ", "url": "https://finviz.com/stock?t=NSPR", "source_name": "Finviz", "published_at": "2026-06-04T17:10:08", "published_display": "04 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) holders OK 250M authorized shares, re-elect directors", "summary": "InspireMD (NSPR) stockholders approved an amendment to increase the authorized number of common shares from 150 million to 250 million at their 2026 annual meeting. The stockholders also re-elected Marvin Slosman, Raymond Cohen, and Dan Dearen to the board of directors for three-", "url": "https://www.stocktitan.net/sec-filings/NSPR/8-k-inspire-md-inc-reports-material-event-34fe2a3ad999.html", "source_name": "Stock Titan", "published_at": "2026-06-03T20:10:41", "published_display": "03 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) Edges Higher as Stock Hovers Near Key Resistance - Put Support", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNNXFNNUtzQUlvbUVEc0FubzVXZEM5cDdON1A1X1k4SmZsQnFteldIaXBMSTJ3LVk3Vm02UTdMTUlxbExsMURvWDZOY2UxV2lWc09FMlNFOFJHa1NVV0RyT2VBWlNCS0phMDR4VERxcDNiM09ZcjhrXzlzQXBWS0VfWjdNc0FEb0dsaG5zLW5kcktiUmRacldqNVB1NE9oMnNZVThxX2Z1cnMzN00?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD NSPR Q1 2026 Earnings Transcript", "summary": "InspireMD (NASDAQ:NSPR) reported robust 122% revenue growth in Q1 2026, primarily driven by the U.S. launch of CGuard Prime and international expansion. However, the company voluntarily paused U.S. commercialization of its CGuard Prime 135 delivery system due to technical feedbac", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/motley/2244851/inspiremd-nspr-q1-2026-earnings-transcript/", "source_name": "The Globe and Mail", "published_at": "2026-06-01T22:10:26", "published_display": "01 Jun 2026 22:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD director Paul Stuka buys $17,500 in shares By Investing.com", "summary": "InspireMD director Paul Stuka recently purchased 20,000 shares of the company's common stock for $17,500, with shares acquired at a weighted average price of $0.8750. This transaction increases his direct holdings to 667,871 shares, occurring while the stock is near its 52-week l", "url": "https://za.investing.com/news/insider-trading-news/inspiremd-director-paul-stuka-buys-17500-in-shares-93CH-4306194", "source_name": "Investing.com South Africa", "published_at": "2026-05-29T21:40:05", "published_display": "29 May 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD director Paul Stuka buys $17,500 in shares", "summary": "InspireMD director Paul Stuka purchased 20,000 shares of the company's common stock for $17,500 on May 27, 2026, when the stock was near its 52-week low. This insider buy comes despite the company facing unspecified operational challenges, although it recently exceeded Q1 2026 an", "url": "https://www.investing.com/news/insider-trading-news/inspiremd-director-paul-stuka-buys-17500-in-shares-93CH-4717241", "source_name": "Investing.com", "published_at": "2026-05-29T20:40:05", "published_display": "29 May 2026 20:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc. (NSPR) Q1 2026 Earnings: Narrower Loss Than Expected But Shares Slide - Pre-Earnings Setup", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPMExwUVM3MnJ2VWxONjNtV3lsN1hFdThFeUNxSWlHYnhWZ0VCVzREbWxWWXdOWTNNSXRxRDBjRmZ4Z3NVd0tYX1RWOWF4OWp1aWppRkFzTHhETk0xVnVrM2tncTd3TFBab21lN3Z2YVdFaDVzRXVvMkduSlVES2VySGllajRTcWNXbVBhNGpVSFVmNm81UFpHTFliVF9tR28zblAtcXl0azBJS2RKZzIxcXRRaTFzaEVCTUI5LTVuUHE?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) Q1 2026 Earnings: EPS Beat Despite Net Loss, Shares Dip 2.9% - Return On Capital", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNcWZvelZlcG8xQTh1cVZfVnREZHhuVUVLejNXaVlSaGdicGp5UGVINnFjckxnYkNOSVNMUmx6SzhrWWE1YWVMMHp1cU1QOU0zaVNRV0RJcnRGU3JxZW9OQjl6QU5hVUV6b2xzUHI5R1R3NmFVWVg3Sl9hX09BX1FOampLWnU4UnZ3TzV2WFp4bFYta3BOcTFRSGtPLV90QXN3QU81QnNabFNpY0ZS?oc=5", "source_name": "M\u011bsto B\u0159eclav", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "InspireMD director Gary Roubin buys $106,200 in company stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQeGJ3TnpWMWgtRVdzV05wV0lXamwzSVpCZ1VJMVJLMXk4dGlSSU1zUWMtaVhnMTNFdTVfUXRQTHdVUnhtRGdRbENObzlQZkJPNFloWlBqT0tDakZMU3l1bGlYSHhyeHpoRm9DRTB4U3JzUXdNYTVPSHA4M1VLOENtbC1ITFZxYmV3bnZuWWRSSUpyUnVfSEc4VldHMEZLM1B1aC1jX0QwWVIyUTZkMnJ3NlRxUVp1bkxvaGY0bU1zYV9Xdw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/inspiremd-participate-upcoming-bank-america-200500837.html", "source_name": "GlobeNewswire", "published_at": "2026-05-06T20:05:00+00:00", "published_display": "06 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/2d83cf2a-e43b-3023-8279-e865710f0857/inspiremd%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-05T12:30:00+00:00", "published_display": "05 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "InspireMD (NSPR) Q4 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/4a744716-4bf6-3a77-9639-5b478e1db797/inspiremd-%28nspr%29-q4-2025.html", "source_name": "Motley Fool", "published_at": "2026-05-04T21:28:00+00:00", "published_display": "04 May 2026 21:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) Q2 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/2cc313d8-a4f8-35d8-b94b-d8faadaeed3f/inspiremd-%28nspr%29-q2-2025.html", "source_name": "Motley Fool", "published_at": "2026-05-04T21:26:53+00:00", "published_display": "04 May 2026 21:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) Q3 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/c9a4ed40-1311-3932-9313-766cb36becc5/inspiremd-%28nspr%29-q3-2025.html", "source_name": "Motley Fool", "published_at": "2026-05-04T21:25:38+00:00", "published_display": "04 May 2026 21:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA lets InspireMD start pivotal study of stroke-protection device", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNT3dpdmY1SzRvZ2lpcTFyaXhpZUJsSmVTNERYNFB1NHV1R2F3X294Z2tZR3RIUWhBUDFDVDR5SlpyZjVadkV6Nk4wZnB6YTNtWURqR1A2YXVWUElvX1dISUNsMWhpSlZXTW50YWwzWGpxQVpVbEpsaW9zN3NxVzl3WWdRM01ZZkRVbjdjbS1qYS1talhzMkpGeTBLWEwwMnRrbFBDWEltUGpvWnJwZXk5TW5QbDE?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Reports 53% Year-Over-Year Unit Sales Growth Amid Anticipated FDA Approvals and Voluntary Recall of CGuard Prime 135 cm Delivery System | NSPR Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAJBVV95cUxNQ2JDOGZ5eHFsbnJ3bmwyd190cXhUbDNZaDNJLWxwOUNwTnJvQXRSdzFjZjU3OE5IdmdXNU1NLTlSWUhLMzVjVlRRaEppazJSMWpzd1pXb3ptRFlSc3lLODBIZE8xMTVsZmMwbjFQYm9JTk56Zm11d2tqU1lmWnhsSFJZOWtSazQxaGZsTDhMQ1lDZFR6eDQzMTQtalR6LWhRVDZmTzIxblhTSll1cGZ2UVI2dWs3SlBwYXVsZTdDa3E4VTBIemduZURJLXFlT3ozWnRoR3ZyeVFNU2xRd0ZGS0JCeDVSUmZFTE9jNVlBQnY2MG1SM1JnLWRMbndfMERJRHJqUnJiM0pDQVNE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "InspireMD (NSPR) CEO Marvin Slosman reports 5.18% beneficial stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOeGo1UXJvRGFwZ2tNZ21YZ05qdkFyNTB6bUNCUm5WaWRVOWMycmJMNnBfeEFlN0RHSkVrOXY1aUJnN1NPLTU4elZiUFg0TEZQWlFOZUJ4eUc2WGVPMVJEdU5zcUc3TG56UjcyanZKblNON180Q2xoZUlaTXllYk9VN3ZrWENZM0xiR3VrY1JkWEF4LWQ0MTRRdFV3b3N5SHZVRXFrNURPdnB0ZkJMR0xocGpYNElnMjVCOHdkcVN3?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQU0N1MVc0VjBnekhzY2l5YTRDTG9NandnVEpCTHRDbXRnZFI2Y2dCN2NUT1hqbjQ5QzQtWlJuQlRnNVhwNlE2VU5lc2xDMmtGTjRueWFtamlWTXRMR1p0WVlxWVhvZF90dE5aNnR2bWExcUJGM2pXRFo1SzlzQjN4LTRwakpYcG41S0hTNU9LSQ?oc=5", "source_name": "Market source", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "This Insider Has Just Sold Shares In InspireMD", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "40,513 Restricted Shares: InspireMD Grants Inducements to 3 New Employees with 3-Year Vesting", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPLTUyUDFuMmhFLU4xWGRENGZZSWNYenExdFF0VUdpMjNPdF9tRmtfcmI0VXctVFZWbmJ0WTZEVVRLNnNZdkN2LV9QSHFIUTc5NjFGcVBMLVlzQXpHSHJsMHl6dFQ1azZjM1dSUXRhcXZIc00zZ3dIVXBHWUIyWVlYeGxqeUU3LXlHbmttSU1IQTN4dXlYYjdIOFNnQU93V0JuYXVZQTBpVjZYOER1NmVJZUZyS0NTMmJ4UzBV?oc=5", "source_name": "Stock Titan", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inspiremd (NSPR) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1VX1FqVWd2MlNmRndzc2tGMHpkUjJXNUxWYi1WWXZlZFFxSml4ZWhJTkl1LXdyd1lhdlduTklNYVBhWFBvY0FkSENqR1ZNVWdZbDJz?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:59:45+00:00", "published_display": "25 Apr 2025 00:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Announces Private Placement of Up to $113.6 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNX2lpUm5kRU8yaUk5WFRtMUl6VXBCeGpVUXVjWTVXUTNwMFFzbExLdEU0aXh6OWItMTVMNG9OTmxScU95US1EUVI0VVBfVGE4VURzZEphTk5PUEFjZVRKRHYyV2dxR0FUR1ZZTkU4akUwMTJDNFdvLXVJSlhzSXlCVHdYdnc5NXFTYjJYblpfNWc2VlFjaHFyaTUydkZ2cmtOczlpY2RIeGtzUDVKT0o2Rk9VWFo3aGg1UFhZLW56NGlWcU55dy12TGQ0bTU?oc=5", "source_name": "GlobeNewswire", "published_at": "2023-05-15T07:00:00+00:00", "published_display": "15 May 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "InspireMD director Raymond W. Cohen to resign from board effective July 1, 2026", "summary": "Raymond W. Cohen is resigning from his position as a Class III Director at InspireMD, effective July 1, 2026, due to personal considerations. He also served on the Audit Committee and Compensation Committee. The company's Nominating and Corporate Governance Committee will be resp", "url": "https://www.tradingview.com/news/tradingview:812d859cb06a6:0-inspiremd-director-raymond-w-cohen-to-resign-from-board-effective-july-1-2026/", "source_name": "TradingView", "published_at": "2026-07-03T07:29:37", "published_display": "03 Jul 2026 07:29", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Board member Raymond Cohen to leave InspireMD (NSPR) effective July 1, 2026", "summary": "InspireMD, Inc. reported that board member Raymond W. Cohen, a Class III director and member of the Audit and Compensation Committees, will resign effective July 1, 2026. His resignation is for personal considerations and is not due to any disagreement with the company. The Nomin", "url": "https://www.stocktitan.net/sec-filings/NSPR/8-k-inspire-md-inc-reports-material-event-a40e8150aab0.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:39:37", "published_display": "02 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $4", "summary": "Lake Street has reiterated its Buy rating on InspireMD (NSPR.US) but has adjusted its price target for the stock down to $4. This indicates a continued positive outlook on the company despite a revised valuation.", "url": "https://www.moomoo.com/news/post/69344277/lake-street-maintains-inspiremd-nsprus-with-buy-rating-cuts-target", "source_name": "Moomoo", "published_at": "2026-06-30T16:40:33", "published_display": "30 Jun 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD, Inc.(NasdaqCM: NSPR) dropped from Russell 3000E Growth Benchmark", "summary": "InspireMD, Inc. (NasdaqCM: NSPR) has been removed from the Russell 3000E Growth Benchmark. This news comes after several recent announcements from InspireMD regarding recalling actions on its CGuard Prime Carotid Stent System and enrolling the first patient in a new pivotal study", "url": "https://www.marketscreener.com/news/inspiremd-inc-nasdaqcm-nspr-dropped-from-russell-3000e-growth-benchmark-ce7f5fdeda8ef125", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T05:13:20", "published_display": "29 Jun 2026 05:13", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD, Inc.(NasdaqCM:NSPR) dropped from Russell Microcap Growth Benchmark Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPT3RKRzBlWFk2S2p1MnktbENWRFVoNXdpLS1jeFVKNllhT0Fycmp2OVJGb1ZIanVTS09mZmpwMHFhS19QVWVWeG9DQm9keFpPQ3NoRXUyM2I5emk1OEhfcnljaVN0V0pVNVJOQlJZT0lTMlhnU1o0TGMzYzRlVzdIcEVJYTAxUVhUZEhwaUpKd3FfWElTVmFWWFJHcmh5empRX0kwZ2JPenBVUVhmWG9kSnNRZTJtaTRrdmhVNC1yRVRUUy1DMmlXdjN2eVJkZw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NSPR Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a stock forecast for InspireMD Inc. (NSPR) for 2027, including analyst price targets, historical performance data, and key financial metrics. It details the current stock price, volatility, market capitalization, and upcoming earnings report date, also highl", "url": "https://www.tradingview.com/symbols/NASDAQ-NSPR/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-28T07:40:38", "published_display": "28 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of InspireMD Inc. \u2013 NASDAQ:NSPR", "summary": "This article provides financial data for InspireMD Inc. (NASDAQ:NSPR), specifically focusing on its price-to-book forward ratio. It appears to be an entry from a financial data platform, displaying market information, but the actual numerical value for the price-to-book forward r", "url": "https://www.tradingview.com/symbols/NASDAQ-NSPR/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T17:10:09", "published_display": "27 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of InspireMD Inc. \u2013 NASDAQ:NSPR", "summary": "This article provides the \"Price to sales forward\" value for InspireMD Inc. (NASDAQ: NSPR). The financial data is delivered by TradingView, sourcing information from ICE Data Services and FactSet Research Systems Inc.", "url": "https://www.tradingview.com/symbols/NASDAQ-NSPR/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:40:37", "published_display": "27 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of InspireMD Inc. \u2013 NASDAQ:NSPR", "summary": "This article provides financial data for InspireMD Inc. (NASDAQ: NSPR), specifically focusing on its enterprise value to revenue forward. It appears to be a stub or a data point from a financial platform like TradingView, with no further analytical content but highlights the comp", "url": "https://www.tradingview.com/symbols/NASDAQ-NSPR/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T01:40:14", "published_display": "26 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of InspireMD Inc. \u2013 NASDAQ:NSPR", "summary": "This page from TradingView provides financial data for InspireMD Inc. (NASDAQ:NSPR), specifically focusing on its enterprise value to EBITDA forward metric. The content highlights the company's financial overview within the health technology and medical specialties sector.", "url": "https://www.tradingview.com/symbols/NASDAQ-NSPR/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T20:11:03", "published_display": "25 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of InspireMD Inc (NSPR), listing its major shareholders, their proportion of holdings, and recent changes in their positions. It also provides institutional shareholding data over several quarters, showing the number of institutions,", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T11:10:35", "published_display": "18 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Institutional Confidence", "summary": "InspireMD Inc (NSPR) has an institutional shareholding score of 3.00, placing it 132nd out of 203 in the Healthcare Equipment & Supplies industry. Institutional holdings represent 49.38% of shares outstanding, a 9.65% decrease quarter-over-quarter. James Simons is the largest ins", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T11:09:11", "published_display": "18 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides details on InspireMD Inc (NSPR)'s dividend and stock split history. It notes that the company has not distributed dividends in the past five years and lists several 15-to-1 merger-type stock splits that occurred on April 15, 2021. The article also presents c", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T21:09:43", "published_display": "17 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of InspireMD Inc (NSPR), detailing its current price momentum score of 5.92 and noting it trades between resistance at $0.96 and support at $0.58. It breaks down various technical indicators, with a majority signaling \"Sell,\" and highlig", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/technical", "source_name": "TradingKey", "published_at": "2026-06-17T11:09:06", "published_display": "17 Jun 2026 11:09", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Financial Health: Profitability & Balance Sheet Analysis", "summary": "InspireMD Inc's current financial score is 6.38, ranking 157 out of 203 in its industry, indicating robust financial status but low operating efficiency. The company reported a 122.24% year-over-year increase in quarterly revenue to $3.40M and a 22.60% increase in net profit. Key", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T11:09:05", "published_display": "17 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc (NSPR) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "InspireMD Inc (NSPR) has an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $4.50, with forecasts ranging from $4.00 to $5.00, suggesting a significant upside. The market expects NSPR t", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-nspr/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T11:09:05", "published_display": "17 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR", "summary": "InspireMD announced positive 30-day results from its CGUARDIANS II clinical trial for the CGuard Prime 80 cm carotid stent implant used in TCAR procedures, meeting key safety and efficacy endpoints with a 100% acute device success rate and no adverse events. This data supports po", "url": "https://finance.yahoo.com/healthcare/articles/inspiremd-posts-positive-cguardians-ii-164100594.html", "source_name": "Market source", "published_at": "2026-06-16T11:41:17", "published_display": "16 Jun 2026 11:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD announces inducement grants", "summary": "InspireMD, Inc. has announced that its Compensation Committee approved inducement grants of 91,161 shares of restricted stock to six new non-executive employees. These grants, made outside of the company's 2021 Equity Incentive Plan under the 2024 Inducement Plan, are intended to", "url": "https://medicalbuyer.co.in/inspiremd-announces-inducement-grants-3/", "source_name": "Medical Buyer", "published_at": "2026-06-15T10:09:34", "published_display": "15 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "InspireMD, Inc. (Nasdaq: NSPR) announced that its Compensation Committee approved inducement grants of 91,161 shares of restricted stock to six new non-executive employees. These grants were made outside of the company's 2021 Equity Incentive Plan but under the 2024 Inducement Pl", "url": "https://www.manilatimes.net/2026/06/13/tmt-newswire/globenewswire/inspiremd-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/2364711", "source_name": "The Manila Times", "published_at": "2026-06-12T20:09:19", "published_display": "12 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Six new InspireMD employees receive 91,161-share stock grants", "summary": "InspireMD (Nasdaq: NSPR) has announced inducement grants of 91,161 restricted shares to six new non-executive employees under its 2024 Inducement Plan. These equity awards, granted outside the 2021 Equity Incentive Plan per Nasdaq Listing Rule 5635(c)(4), will vest over three yea", "url": "https://www.stocktitan.net/news/NSPR/inspire-md-announces-inducement-grants-under-nasdaq-listing-rule-73rxuoq82m9y.html", "source_name": "Stock Titan", "published_at": "2026-06-12T20:09:19", "published_display": "12 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD, Inc. (NSPR) reports Q1 loss, tops revenue estimates", "summary": "InspireMD, Inc. (NSPR) announced its first-quarter financial results, reporting a loss per share that was wider than analyst expectations but surpassing revenue estimates. The company posted a loss of 19 cents per share against an anticipated loss of 18 cents, while revenue reach", "url": "https://www.msn.com/en-us/money/other/inspiremd-inc-nspr-reports-q1-loss-tops-revenue-estimates/ar-AA22nYF5?ocid=BingNewsVerp", "source_name": "MSN", "published_at": "2026-06-12T00:39:46", "published_display": "12 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/inspiremd-announces-30-day-results-120000676.html", "source_name": "GlobeNewswire", "published_at": "2026-06-11T12:00:00+00:00", "published_display": "11 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stroke-prevention stent hits 100% success in 50 high-risk patients", "summary": "InspireMD (NSPR) announced 30-day results from its CGUARDIANS II clinical trial for the CGuard Prime 80 cm stent used in TCAR procedures, showing 100% acute device success and no major adverse events in 50 high-risk patients. The company has a PMA supplement under FDA review with", "url": "https://www.stocktitan.net/news/NSPR/inspire-md-announces-30-day-results-from-the-cguardians-ii-clinical-84bv5ee39qxg.html", "source_name": "Stock Titan", "published_at": "2026-06-11T12:39:26", "published_display": "11 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) reports 100% device success in TCAR trial", "summary": "InspireMD (NSPR) announced strong 30-day results from its CGUARDIANS II clinical trial for the CGuard Prime 80 cm implant used in TCAR procedures, showing 100% device success and no major adverse events in 50 patients. The company has a Premarket Approval supplement under FDA rev", "url": "https://www.stocktitan.net/sec-filings/NSPR/8-k-inspire-md-inc-reports-material-event-1b822d3a9585.html", "source_name": "Stock Titan", "published_at": "2026-06-11T11:39:26", "published_display": "11 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures", "summary": "InspireMD has announced the enrollment of the first patient in its CGUARDIANS III pivotal study, evaluating the SwitchGuard neuro protection system for use in TCAR procedures with the CGuard Prime 80 cm stent. This study aims to enhance patient safety and stroke prevention, build", "url": "https://www.globenewswire.com/news-release/2026/06/08/3308025/0/en/inspiremd-announces-first-patient-enrolled-in-the-cguardians-iii-pivotal-study-of-the-switchguard-neuro-protection-system-for-use-in-tcar-procedures.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T06:40:38", "published_display": "09 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NSPR - InspireMD Inc Stock Price and Quote", "summary": "This page provides a detailed overview of InspireMD Inc (NSPR) stock, including its current trading price, financial metrics, performance indicators, and recent news. It lists key financial data such as market cap, income, sales, and various ratios, alongside insider transaction ", "url": "https://finviz.com/stock?t=NSPR", "source_name": "Finviz", "published_at": "2026-06-04T17:10:08", "published_display": "04 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) holders OK 250M authorized shares, re-elect directors", "summary": "InspireMD (NSPR) stockholders approved an amendment to increase the authorized number of common shares from 150 million to 250 million at their 2026 annual meeting. The stockholders also re-elected Marvin Slosman, Raymond Cohen, and Dan Dearen to the board of directors for three-", "url": "https://www.stocktitan.net/sec-filings/NSPR/8-k-inspire-md-inc-reports-material-event-34fe2a3ad999.html", "source_name": "Stock Titan", "published_at": "2026-06-03T20:10:41", "published_display": "03 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) Edges Higher as Stock Hovers Near Key Resistance - Put Support", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNNXFNNUtzQUlvbUVEc0FubzVXZEM5cDdON1A1X1k4SmZsQnFteldIaXBMSTJ3LVk3Vm02UTdMTUlxbExsMURvWDZOY2UxV2lWc09FMlNFOFJHa1NVV0RyT2VBWlNCS0phMDR4VERxcDNiM09ZcjhrXzlzQXBWS0VfWjdNc0FEb0dsaG5zLW5kcktiUmRacldqNVB1NE9oMnNZVThxX2Z1cnMzN00?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD NSPR Q1 2026 Earnings Transcript", "summary": "InspireMD (NASDAQ:NSPR) reported robust 122% revenue growth in Q1 2026, primarily driven by the U.S. launch of CGuard Prime and international expansion. However, the company voluntarily paused U.S. commercialization of its CGuard Prime 135 delivery system due to technical feedbac", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/motley/2244851/inspiremd-nspr-q1-2026-earnings-transcript/", "source_name": "The Globe and Mail", "published_at": "2026-06-01T22:10:26", "published_display": "01 Jun 2026 22:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD director Paul Stuka buys $17,500 in shares By Investing.com", "summary": "InspireMD director Paul Stuka recently purchased 20,000 shares of the company's common stock for $17,500, with shares acquired at a weighted average price of $0.8750. This transaction increases his direct holdings to 667,871 shares, occurring while the stock is near its 52-week l", "url": "https://za.investing.com/news/insider-trading-news/inspiremd-director-paul-stuka-buys-17500-in-shares-93CH-4306194", "source_name": "Investing.com South Africa", "published_at": "2026-05-29T21:40:05", "published_display": "29 May 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD director Paul Stuka buys $17,500 in shares", "summary": "InspireMD director Paul Stuka purchased 20,000 shares of the company's common stock for $17,500 on May 27, 2026, when the stock was near its 52-week low. This insider buy comes despite the company facing unspecified operational challenges, although it recently exceeded Q1 2026 an", "url": "https://www.investing.com/news/insider-trading-news/inspiremd-director-paul-stuka-buys-17500-in-shares-93CH-4717241", "source_name": "Investing.com", "published_at": "2026-05-29T20:40:05", "published_display": "29 May 2026 20:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Inc. (NSPR) Q1 2026 Earnings: Narrower Loss Than Expected But Shares Slide - Pre-Earnings Setup", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPMExwUVM3MnJ2VWxONjNtV3lsN1hFdThFeUNxSWlHYnhWZ0VCVzREbWxWWXdOWTNNSXRxRDBjRmZ4Z3NVd0tYX1RWOWF4OWp1aWppRkFzTHhETk0xVnVrM2tncTd3TFBab21lN3Z2YVdFaDVzRXVvMkduSlVES2VySGllajRTcWNXbVBhNGpVSFVmNm81UFpHTFliVF9tR28zblAtcXl0azBJS2RKZzIxcXRRaTFzaEVCTUI5LTVuUHE?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) Q1 2026 Earnings: EPS Beat Despite Net Loss, Shares Dip 2.9% - Return On Capital", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNcWZvelZlcG8xQTh1cVZfVnREZHhuVUVLejNXaVlSaGdicGp5UGVINnFjckxnYkNOSVNMUmx6SzhrWWE1YWVMMHp1cU1QOU0zaVNRV0RJcnRGU3JxZW9OQjl6QU5hVUV6b2xzUHI5R1R3NmFVWVg3Sl9hX09BX1FOampLWnU4UnZ3TzV2WFp4bFYta3BOcTFRSGtPLV90QXN3QU81QnNabFNpY0ZS?oc=5", "source_name": "M\u011bsto B\u0159eclav", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD director Gary Roubin buys $106,200 in company stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQeGJ3TnpWMWgtRVdzV05wV0lXamwzSVpCZ1VJMVJLMXk4dGlSSU1zUWMtaVhnMTNFdTVfUXRQTHdVUnhtRGdRbENObzlQZkJPNFloWlBqT0tDakZMU3l1bGlYSHhyeHpoRm9DRTB4U3JzUXdNYTVPSHA4M1VLOENtbC1ITFZxYmV3bnZuWWRSSUpyUnVfSEc4VldHMEZLM1B1aC1jX0QwWVIyUTZkMnJ3NlRxUVp1bkxvaGY0bU1zYV9Xdw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/inspiremd-participate-upcoming-bank-america-200500837.html", "source_name": "GlobeNewswire", "published_at": "2026-05-06T20:05:00+00:00", "published_display": "06 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/2d83cf2a-e43b-3023-8279-e865710f0857/inspiremd%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-05T12:30:00+00:00", "published_display": "05 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) Q4 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/4a744716-4bf6-3a77-9639-5b478e1db797/inspiremd-%28nspr%29-q4-2025.html", "source_name": "Motley Fool", "published_at": "2026-05-04T21:28:00+00:00", "published_display": "04 May 2026 21:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) Q2 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/2cc313d8-a4f8-35d8-b94b-d8faadaeed3f/inspiremd-%28nspr%29-q2-2025.html", "source_name": "Motley Fool", "published_at": "2026-05-04T21:26:53+00:00", "published_display": "04 May 2026 21:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) Q3 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/c9a4ed40-1311-3932-9313-766cb36becc5/inspiremd-%28nspr%29-q3-2025.html", "source_name": "Motley Fool", "published_at": "2026-05-04T21:25:38+00:00", "published_display": "04 May 2026 21:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA lets InspireMD start pivotal study of stroke-protection device", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNT3dpdmY1SzRvZ2lpcTFyaXhpZUJsSmVTNERYNFB1NHV1R2F3X294Z2tZR3RIUWhBUDFDVDR5SlpyZjVadkV6Nk4wZnB6YTNtWURqR1A2YXVWUElvX1dISUNsMWhpSlZXTW50YWwzWGpxQVpVbEpsaW9zN3NxVzl3WWdRM01ZZkRVbjdjbS1qYS1talhzMkpGeTBLWEwwMnRrbFBDWEltUGpvWnJwZXk5TW5QbDE?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Reports 53% Year-Over-Year Unit Sales Growth Amid Anticipated FDA Approvals and Voluntary Recall of CGuard Prime 135 cm Delivery System | NSPR Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAJBVV95cUxNQ2JDOGZ5eHFsbnJ3bmwyd190cXhUbDNZaDNJLWxwOUNwTnJvQXRSdzFjZjU3OE5IdmdXNU1NLTlSWUhLMzVjVlRRaEppazJSMWpzd1pXb3ptRFlSc3lLODBIZE8xMTVsZmMwbjFQYm9JTk56Zm11d2tqU1lmWnhsSFJZOWtSazQxaGZsTDhMQ1lDZFR6eDQzMTQtalR6LWhRVDZmTzIxblhTSll1cGZ2UVI2dWs3SlBwYXVsZTdDa3E4VTBIemduZURJLXFlT3ozWnRoR3ZyeVFNU2xRd0ZGS0JCeDVSUmZFTE9jNVlBQnY2MG1SM1JnLWRMbndfMERJRHJqUnJiM0pDQVNE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD (NSPR) CEO Marvin Slosman reports 5.18% beneficial stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOeGo1UXJvRGFwZ2tNZ21YZ05qdkFyNTB6bUNCUm5WaWRVOWMycmJMNnBfeEFlN0RHSkVrOXY1aUJnN1NPLTU4elZiUFg0TEZQWlFOZUJ4eUc2WGVPMVJEdU5zcUc3TG56UjcyanZKblNON180Q2xoZUlaTXllYk9VN3ZrWENZM0xiR3VrY1JkWEF4LWQ0MTRRdFV3b3N5SHZVRXFrNURPdnB0ZkJMR0xocGpYNElnMjVCOHdkcVN3?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQU0N1MVc0VjBnekhzY2l5YTRDTG9NandnVEpCTHRDbXRnZFI2Y2dCN2NUT1hqbjQ5QzQtWlJuQlRnNVhwNlE2VU5lc2xDMmtGTjRueWFtamlWTXRMR1p0WVlxWVhvZF90dE5aNnR2bWExcUJGM2pXRFo1SzlzQjN4LTRwakpYcG41S0hTNU9LSQ?oc=5", "source_name": "Market source", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Insider Has Just Sold Shares In InspireMD", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "40,513 Restricted Shares: InspireMD Grants Inducements to 3 New Employees with 3-Year Vesting", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPLTUyUDFuMmhFLU4xWGRENGZZSWNYenExdFF0VUdpMjNPdF9tRmtfcmI0VXctVFZWbmJ0WTZEVVRLNnNZdkN2LV9QSHFIUTc5NjFGcVBMLVlzQXpHSHJsMHl6dFQ1azZjM1dSUXRhcXZIc00zZ3dIVXBHWUIyWVlYeGxqeUU3LXlHbmttSU1IQTN4dXlYYjdIOFNnQU93V0JuYXVZQTBpVjZYOER1NmVJZUZyS0NTMmJ4UzBV?oc=5", "source_name": "Stock Titan", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Inspiremd (NSPR) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1VX1FqVWd2MlNmRndzc2tGMHpkUjJXNUxWYi1WWXZlZFFxSml4ZWhJTkl1LXdyd1lhdlduTklNYVBhWFBvY0FkSENqR1ZNVWdZbDJz?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:59:45+00:00", "published_display": "25 Apr 2025 00:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InspireMD Announces Private Placement of Up to $113.6 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNX2lpUm5kRU8yaUk5WFRtMUl6VXBCeGpVUXVjWTVXUTNwMFFzbExLdEU0aXh6OWItMTVMNG9OTmxScU95US1EUVI0VVBfVGE4VURzZEphTk5PUEFjZVRKRHYyV2dxR0FUR1ZZTkU4akUwMTJDNFdvLXVJSlhzSXlCVHdYdnc5NXFTYjJYblpfNWc2VlFjaHFyaTUydkZ2cmtOczlpY2RIeGtzUDVKT0o2Rk9VWFo3aGg1UFhZLW56NGlWcU55dy12TGQ0bTU?oc=5", "source_name": "GlobeNewswire", "published_at": "2023-05-15T07:00:00+00:00", "published_display": "15 May 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 90, "total_relevant": 59, "sentiment_summary": {"positive": 7, "negative": 5, "neutral": 47, "score": 51, "total": 59, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 14.3, "count": 26}, {"event": "earnings", "label": "Earnings", "weight": 13.2, "count": 27}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}], "positive_events": 7, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 0.72, "latest_week": "2026-07-10", "one_week_move": 3.0, "four_week_move": -1.4, "twelve_week_move": -46.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.60479, "market_dynamics_buy_signal": false, "relative_strength": -65.693919, "fair_value_gap": -70.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.9487, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.0% over one week, -1.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "Stock Titan", "count": 9}, {"label": "TradingView", "count": 6}, {"label": "TradingKey", "count": 6}, {"label": "GlobeNewswire", "count": 4}, {"label": "Motley Fool", "count": 3}, {"label": "dars.gov.et", "count": 2}, {"label": "Investing.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 47}, {"label": "Industry context", "count": 12}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 27}, {"label": "Market update", "count": 26}, {"label": "Analyst action", "count": 2}, {"label": "Regulatory and legal", "count": 2}, {"label": "Deals and strategy", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "47", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.0% over one week, -1.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "InspireMD director Raymond W. Cohen to resign from board effective July 1, 2026"}], "updated_at": "2026-07-16T11:45:21.860125+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}